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TECHNICAL NOTE
Access for hemodialysis by means of long-term central
venous catheters
WILLIAM P. REED, PAUL D. LIGHT, and JOHN H. SADLER
Department of Surgery and Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore,
Maryland
The vascular access needs of most people requiring long-term
hemodialysis can be maintained over many years by the judi-
cious sequential use of available upper and forearm veins. For
some fortunate patients, a single anteriovenous fistula may be
all that is necessary to provide a lifetime of dialysis access. For
others, repeated failure of conventional access routes may lead
to abandonment of hemodialysis in favor of chronic peritoneal
dialysis. Peritonitis or other problems may eventually restrict
the use of this route, forcing consideration of unconventional
forms of access.
Continuous venous access has been provided for as long as
960 days for parenteral nutrition [11 and as long as 831 days for
chemotherapy [21 by means of surgically implanted silicone
rubber right atrial catheters. The safety of these catheters for
long-term use has been amply demonstrated in high risk pa-
tients with acute leukemia. It has seemed reasonable, therefore,
to adapt a similar device for use as long-term venous access for
hemodialysis in patients lacking more usual access routes.
Methods and Results. The standard implantable right atrial
catheter (Hickman Catheter, Evermed, Medina, Washington) is
90 cm long with an internal diameter of 1.6 mm. A shorter (26
cm) larger bore (2.6 mm I.D.) catheter with a measured internal
volume of 1.25 ml was used for dialysis to reduce resistance for
higher flows. This catheter (Hickman Fistula Catheter,
Evermed, Medina, Washington) was otherwise similar to the
standard one, featuring a silicone rubber tube fitted with a luer-
bk adapter at the external end and a dacron felt cuff encircling
the tubing one third the distance from the external end to the
inner tip, the edge of which has been beveled to provide a
rounded surface for contact with endovascular surfaces. Only a
single opening was present at the inner tip. An opaque stripe
incorporated in the catheter permitted radiographic confirma-
tion of catheter position.
The catheter was implanted into the superior vena cava
through a venotomy in the external jugular vein, exposed
through a 4 to 5 cm transverse cervical incision performed just
above the right clavicle under lidocaine anesthesia. The vein
was usually found to be quite large and easily cannulated. In
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those patients in whom the external jugular vein was of insuffi-
cient size to accept the catheter, the internal jugular vein was
easily exposed through the same incision and cannulated
through a purse-string suture. A subcutaneous tunnel between
the incision and the catheter exit site, which was positioned on
the anterior chest wall just inferior to the clavicle (Fig. 1), was
easily developed by gentle blunt dissection in the manner
previously described by Ivey and Heimbach [3]. The catheter
was tested for ease of blood withdrawal prior to securing it in
place to assure subsequent function. The cervical incision was
closed in two layers with absorbable suture and the catheter
was secured to the exit site for 7 to 10 days with a 3-0
monofilament suture.
Postoperatively, the catheter was flushed daily and after each
dialysis with 10 ml of 0.9% saline followed by 2000 U of heparin
in 2.0 ml of 0.9% saline and sealed with a threaded cap. A
detailed description of the postoperative and home care instruc-
tions has been published previously 12]. The cervical incision
was left uncovered after the first 24 hr, but the exit site was
dressed with a small gauze bandage after daily cleansing with
peroxide and application of povidone iodine ointment.
Six-hour time/time single needle dialysis, without limitation
to venous return, was carried out through a Y-connector of
measured internal volume equal to 0.3 ml, using a compliant
parallel flow dialyzer (Gambro AK-b, Gambro, Lund, Swe-
den), and noncompliant tubing. Peak flows were set at 250 to
300 ml. The percent recirculation (%RC) was calculated accord-
ing to the method recommended by Gambro [4] as %RC =
DS/SY x 100 where the dead space (DS) was measured directly
as 1.55 ml (volume to fill catheter and connector before
implantation) and the stroke volume (SV) was calculated
SV = BFR (
AT
60 sec
The effective blood flow (QB) was calculated
QB = BFR (ATTAv)
with BFR as the blood flow rate determined by a precalibrated
monitor, AT as the time for arterial flow in seconds, and AT +
AV as the time for the total cycle in seconds, Serum samples
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were obtained at the beginning and end of dialysis for automat-
ed BUN and creatinine determination by the hospital
laboratory.
To date these modified catheters (Hickman) have been used
to provide repeated venous access for hemodialysis in ten
patients for 2 to 198 days (mean, 80.5 days). Six of these
catheters have continued to function 71 to 198 days after
implantation (mean, 108 days). Two functioning catheters were
removed 22 and 48 days after insertion when alternative vascu-
lar access sites matured sufficiently to permit resumption of
conventional hemodialysis. Two other patients died of abdomi-
nal sepsis 2 and 83 days after catheter placement. In each case
the abdominal infection predated and contributed to the selec-
tion of a central venous route of access. One of these patients
required alternative access when she developed candida perito-
nitis after 2 years of chronic ambulatory peritoneal dialysis
made necessary by obliteration of the last of her peripheral
veins. Although this patient ultimately succumbed to persistent
peritoneal sepsis, she was maintained on hemodialysis by
means of the catheter through three abdominal explorations
over an 11-week period. The catheter was also used to adminis-
ter parenteral nutrition between dialyses. Postmortem examina-
tion showed that her septic focus was confined to the peritoneal
cavity; the catheter was free of thrombi or organisms. The other
patient was a massively obese (170 kg) diabetic female who
developed acute renal failure as a consequence of necrotizing
fasciltis of the abdominal wall. A central venous catheter was
implanted because reliable percutaneous cannulation was pre-
cluded by the patient's obesity. The catheter worked well for
the 2 remaining days of life of this desperately ill woman.
There were no complications associated with catheter inser-
tion. No hemolysis was observed; hematocrits remained stable
unless specific blood loss was identified. No episodes of
thrombosis developed in any patient, nor did any of the
catheters become infected during the period of use. One patient
did develop increased resistance to flow in the catheter after 1
month of use. This cleared rapidly with a 12-hr infusion of
streptokinase delivered at the rate of 1000 U/hr by pump
(Harvard Apparatus, Mills, Massachusetts) at a concentration
of 1000 U/10 ml.
Postdialysis chemistries were similar to those obtained with a
standard two-needle technique (Table 1). By attaching the low
volume Y-connector directly to the catheter, a dead space of
1.55 ml for the entire apparatus was obtained. Flow through the
superior vena cava is believed to be sufficiently large to prevent
recirculation of blood returned from the dialyzer into that
vascular space. Calculated recirculation was less than 15% of
blood flow through the dialyzer on the six patients for whom
this value was determined (Table 1).
Obligatory ultrafiltration occurred as a function of the 180 to
300 mm Hg venous pressures developing during arterial flow,
when the venous end of the system was closed. The degree of
fluid replacement required varied from patient to patient de-
pending on the amount of excess fluid present at the onset of
dialysis. Although individual fluid requirements varied, the
replacement needed for a given patient was relatively constant
from dialysis to dialysis.
Discussion. This device offers immediately usable access in
circumstances where more conventional access routes need
time to mature or where no peripheral veins remain. Prelimi-
nary experience shows that adequate and repeated dialysis,
without the need for catheter change, can be carried out for as
long as 6 months. While no catheter has yet been used for a
longer period of time, our experience with other high risk
patients, such as those with acute leukemia, would suggest that
a useful catheter life of 2 to 3 years would not be an unreason-
able expectation. This potential longevity provides a decided
advantage over percutaneously placed subclavian lines, in the
patient with no arteriovenous or peritoneal access who requires
long-term dialysis. Whether it is a better form of access,
however, is in part a function of the anticipated longevity
required. We feel the cut-down method of insertion utilized
does preclude the potentially serious hazards of pneumothorax,
hemothorax, and arterial cannulation that are occasionally seen
with blind percutaneous placement of other central lines [5, 6].
Infection and thrombosis have not occurred in these immuno-
compromised hosts. Experience with similar catheters in se-
verely granulocytopenic patients with leukemia has demon-
strated a bacteremic rate of fewer that 0.5 episodes per 100 days
of catheter use (2). Ninety percent of these episodes occurred in
association with granulocyte counts that were less than 1000
cells per mm3, usually at a time of disease relapse. Foci of
infection, such as pneumonias, periodontal disease, or perirec-
tal abscesses, could usually be found to account for the sepsis,
and almost all could be successfully treated with appropriate
antibiotics without removing the catheters. Experience with a
more limited number of nonleukemic cancer patients suggests
that an even lower rate of sepsis can be expected in patients
with normal levels of granulocytes.
The volume of flow in the superior vena cava and the low
volume (1.25 ml) of the catheter avoid serious recirculation.
The venous pressures developing during the arterial flow
phases, when the venous tubing is clamped, produce ultrafiltra-
N
Fig. 1. Catheter in place after cannulation of external jugular vein.
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Table 1. Blood chemistries and catheter flows obtained using the implantable central venous dialysis catheter
BUN Creatine
Preset Stroke ________
Patient Weight blood flow QB volume AT Recirculaton Pre- Post- Pre- Post-
no. kg mi/mm mi/mm ml AT + AV % dialysis dialysis dialysis dialysis
1 99 — — — — — 61 33 4.7 1.6
2 45 — — — — — — — — 2.4
3 75 — — — — — 81 33 9.2 5.6
4 170 — — — 106 78 (4 hr) 8.2 7.3 (4 hr)
5 99 250 217 16.7 4.0/4.6 9.3 89 21 15.4 5.7
6 54 275 206 14.6 3.2/4.2 10.6 89 29 12.7 5.8
7 55 300 240 20 4.0/5.0 7.8 87 47 17.2 9.4
8 66 250 175 15.8 3.8/4.6 9.8 102 34 6.8 3.0
9 80 275 192.5 13.8 3.0/4.2 11.2 89 29 12.7 5.8
10 96 250 162 12.5 3.0/4.0 12.4 95 44 13.8 7.4
tion rates on the Gambro AK-tO machine which are high for
some patients. Close monitoring and fluid replacement were
required during most dialyses. This was considered acceptable
under the circumstance of absent alternative access but not for
the patient still able to use more conventional routes. Develop-
ment of larger bore modifications of the newer dual lumen
catheters now available for chemotherapy [71 may permit
adaptation of long-term central venous access to double-needle
dialysis, avoiding the ultrafiltration seen in this system.
Reprint requests to Dr. W. P. Reed, Surgical Oncology Program,
University of Maryland Hospital, 22 South Greene Street, Baltimore,
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